Aneurysmal Subarachnoid Hemorrhage clinical trials

Explore recruiting aneurysmal subarachnoid hemorrhage clinical trials.

Recruiting aneurysmal subarachnoid hemorrhage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aneurysmal Subarachnoid Hemorrhage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial (DASH)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

FINISHER – Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Is adding Cilostazol to nimodipine improving neurological outcome of patients with Aneurysmal Subarachnoid Hemorrhage? A randomized, double blind, placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stereotactic Cisternal Lavage Therapy in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial - SPLASH

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

TicAgreLor versus placebo to prevent cerebral ISCHemia in anEuRysmal low grade SAH A double blinded randomised controlled study TALISCHER - SAH

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aneurysmal Subarachnoid Hemorrhage trials by city

Aneurysmal Subarachnoid Hemorrhage in Toronto Aneurysmal Subarachnoid Hemorrhage in Vancouver Aneurysmal Subarachnoid Hemorrhage in Montreal Aneurysmal Subarachnoid Hemorrhage in Calgary Aneurysmal Subarachnoid Hemorrhage in Edmonton Aneurysmal Subarachnoid Hemorrhage in Ottawa Aneurysmal Subarachnoid Hemorrhage in Winnipeg Aneurysmal Subarachnoid Hemorrhage in Quebec City Aneurysmal Subarachnoid Hemorrhage in Hamilton Aneurysmal Subarachnoid Hemorrhage in Kitchener Aneurysmal Subarachnoid Hemorrhage in London Aneurysmal Subarachnoid Hemorrhage in Halifax Aneurysmal Subarachnoid Hemorrhage in New York Aneurysmal Subarachnoid Hemorrhage in Los Angeles Aneurysmal Subarachnoid Hemorrhage in Chicago Aneurysmal Subarachnoid Hemorrhage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease